196 related articles for article (PubMed ID: 22358341)
1. [Women with polycystric ovary syndrome have a higher frequency of metabolic syndrome regardless of body mass index].
Melo AS; Macedo CS; Romano LG; Ferriani RA; Navarro PA
Rev Bras Ginecol Obstet; 2012 Jan; 34(1):4-10. PubMed ID: 22358341
[TBL] [Abstract][Full Text] [Related]
2. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
Zhang HY; Zhu FF; Xiong J; Shi XB; Fu SX
BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
[TBL] [Abstract][Full Text] [Related]
4. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index.
Rodrigues CE; Ferreira Lde L; Jansen K; Lopez MR; Drews Júnior CR; Souza LD
Rev Bras Ginecol Obstet; 2012 Oct; 34(10):442-6. PubMed ID: 23288220
[TBL] [Abstract][Full Text] [Related]
6. The frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenism.
Melo AS; Vieira CS; Romano LG; Ferriani RA; Navarro PA
Reprod Sci; 2011 Dec; 18(12):1230-6. PubMed ID: 22096008
[TBL] [Abstract][Full Text] [Related]
7. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
8. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
Ni RM; Mo Y; Chen X; Zhong J; Liu W; Yang D
Eur J Endocrinol; 2009 Sep; 161(3):411-8. PubMed ID: 19542239
[TBL] [Abstract][Full Text] [Related]
10. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
[TBL] [Abstract][Full Text] [Related]
11. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
[TBL] [Abstract][Full Text] [Related]
13. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
[TBL] [Abstract][Full Text] [Related]
15. Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.
Panidis D; Tziomalos K; Macut D; Kandaraki EA; Tsourdi EA; Papadakis E; Katsikis I
Gynecol Endocrinol; 2013 Oct; 29(10):926-30. PubMed ID: 23885694
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
18. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
19. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
Carmina E; Campagna AM; Lobo RA
Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
[TBL] [Abstract][Full Text] [Related]
20. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
